Technical Analysis for GLMD - Galmed Pharmaceuticals Ltd.

Grade Last Price % Change Price Change
grade F 3.86 1.58% 0.06
GLMD closed up 1.58 percent on Tuesday, October 15, 2019, on 68 percent of normal volume.

Earnings due: Nov 4

*** please verify all earnings dates ***

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical GLMD trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Wide Bands Range Expansion 0.00%
Up 3 Days in a Row Strength 0.00%
Oversold Stochastic Weakness 0.00%
Wide Bands Range Expansion 1.58%
Oversold Stochastic Weakness 1.58%
New Downtrend Bearish 4.32%
Wide Bands Range Expansion 4.32%
Oversold Stochastic Weakness 4.32%
New 52 Week Closing Low Bearish 6.34%

Older signals for GLMD ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
GalMed Medical Research Ltd. researches and develops proprietary drugs for the treatment of lipid metabolism related diseases. The company has developed a series of proprietary fatty acid bile-acid conjugates (FABACs) which selectively inhibit the enzyme Stearoyl-CoA Desaturase (SCD1), a key regulator in lipid metabolism. It's flagship clinical compound Aramchol (arachidyl amido cholanoic acid), has the potential to modify several of the key disorders related to lipid metabolism, including fatty liver, gallstones, diabetes, hyperlipidemia, cancer, and alzheimer's disease. The company is based in Tel Aviv, Israel. GalMed Medical Research Ltd. operates as a subsidiary of Galmed International Ltd.
Cancer Diabetes Alzheimer's Disease Hepatology Lipid Hyperlipidemia Metabolism
Is GLMD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 12.25
52 Week Low 3.42
Average Volume 84,812
200-Day Moving Average 6.7545
50-Day Moving Average 4.8461
20-Day Moving Average 4.4266
10-Day Moving Average 3.874
Average True Range 0.3145
ADX 28.3
+DI 12.8554
-DI 30.5795
Chandelier Exit (Long, 3 ATRs ) 4.4865
Chandelier Exit (Short, 3 ATRs ) 4.3635
Upper Bollinger Band 5.6011
Lower Bollinger Band 3.2521
Percent B (%b) 0.26
BandWidth 53.065558
MACD Line -0.3686
MACD Signal Line -0.3233
MACD Histogram -0.0453
Fundamentals Value
Market Cap 47.16 Million
Num Shares 12.2 Million
EPS -1.22
Price-to-Earnings (P/E) Ratio -3.16
Price-to-Sales 98.60
Price-to-Book 15.87
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 4.19
Resistance 3 (R3) 4.17 4.03 4.14
Resistance 2 (R2) 4.03 3.95 4.05 4.12
Resistance 1 (R1) 3.95 3.90 3.99 3.97 4.10
Pivot Point 3.81 3.81 3.84 3.83 3.81
Support 1 (S1) 3.73 3.73 3.77 3.75 3.62
Support 2 (S2) 3.59 3.68 3.61 3.60
Support 3 (S3) 3.51 3.59 3.59
Support 4 (S4) 3.53